Viral burden and disease progression in HIV-1-infected patients with sickle cell anemia

American Journal of Hematology

Volumn 59, Issue 3, 1998, Pages 199-207

  Bagasra, Omar ^a   Steiner, Robert M ^a,f   Ballas, Samir K ^a   Castro, Oswaldo ^b   Dornadula, Geethanjali ^a   Embury, Stephen ^c   Jungkind, Donald ^a   Bobroski, Lisa ^a   Kutlar, Abdullah ^d   Burchott, Sandra ^e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Anemia; DNA; HIV 1 sickle cell; RNA

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SICKLE CELL ANEMIA; SPLENECTOMY; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ATROPHY; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PROVIRUSES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SPLEEN; VIRAL LOAD;

EID: 0031792483     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199811)59:3<199::AID-AJH4>3.0.CO;2-L     Document Type: Article

References (60)

1. Wei X, Ghosh SK, Taylor ME: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117, 1995.
2. Ho DD, Neumann AU, Perelson AS: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123, 1995.
3. Coffin JM: HIV population dynamics in vivo: Implications for genetic variation, pathogenesis and therapy. Science 267:483, 1995.
4. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183, 1993.
5. Dianzani F, Antonelli G, Riva E, Uccini S, Visco G: Plasma HIV viremia and viral load in lymph nodes. Nature Med 2:832, 1996.
6. Piatak M, Jr, Saag MS, Yang LC: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749, 1993.
7. Graziosi C, Pantaleo G, Burtini L: Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 90:6405, 1993.
8. Pantaleo G, Graziosi C, Demarest JF: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355, 1993.
9. Ho DD, Moudgil T, Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321:1621, 1989.
10. Connor RI, Mohri H, Cao Y, Ho DD: Increased viral burden and cytopathology correlate temporally with CD4+ T-lymphocyte decline and clinical progress in human immunodeficiency virus type 1-infected individuals. J Viral 67:1772, 1993.
11. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ: Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reactions. N Engl J Med 326:1385, 1992.
12. Bagasra O, Pomerantz RJ: In situ polymerase chain reaction and HIV-1. Clin Lab Med 14:351, 1994.
13. Ma TS: Applications and limitations of polymerase chain reaction amplification. Chest 108:1393, 1995.
14. Patterson BK, Till M, Otto P: Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260:976, 1993.
15. Embretson J, Zupancic M, Ribas JL: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359, 1993.
16. Bagasra O, Seshamma T, Oakes JW, Pomerantz RJ: High percentages of CD4 positive lymphocytes harbor the HIV-1 provirus in the blood of certain infected individuals. AIDS 7:1419, 1993.
17. Hu DJ, Dondero TJ, Rayfield MA: The emerging genetic diversity of HIV. J Am Med Assoc 275:210, 1996.
18. Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W: The characterization of non-progressors: Long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 7:1159, 1993.
19. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD: Long term HIV-1 infection without immunologic progression. AIDS 8:1123, 1994.
20. Lifson AR, Buchbinder SP, Sheppard H: Long term human immunodeficiency virus infection in asymptomatic homosexuals and virological characteristics. J Infect Dis 163:959, 1991.
21. Deacon NJ, Tsykin A, Solomon A: Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 270:988, 1995.
22. Kestler HW, Ringler DJ, Mori K: Importance of the nef gene for maintenance of high virus loads and/or development of AIDS. Cell 65:651, 1991.
23. Huang Y, Zhang L, Ho DD: Characterization of net sequences in long term survivors of human immunodeficiency virus type 1 infection. J Virol 69:93, 1995.
24. Kirchhoff F, Grenough TC, Brettler DB, Sullivan JL, Desrosiers RC: Brief report: Absence of intact nef sequences in a long term survivor with nonprogressive HIV-1 infection. N Engl J Med 332:228, 1995.
25. Huang Y, Paxton WA, Wolinsky SM: The role of the mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 2:1240, 1996.
26. D'Souza MP, Harden VA: Chemokines and HIV-1 second receptors. Nature Med 2:1299, 1996.
27. Pandit HM: Potential use of globins and their derivatives of abnormal blood cells in the treatment of cancer and related immune disorders. Med Hypotheses 40:332, 1993.
28. Steiner RM, Ballas S, Castro O: The role of sickle cell hemoglobinopathy in AIDS. 14th National Sickle Cell Conference, Mobile, Alabama, 1996.
29. Pearson HA, Gallagher D, Chilcote R: Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics 76:392, 1985.
30. Waweru SEN, Meme JS, Kinuthia DM, Kitoyi GW: Absence of HIV seropositivity in children with sickle cell anemia at Kenyatta National Hospital, Nairobi, Kenya (abstract MBP160). Int Conf AIDS 5:248, 1989.
31. Waweru SEN, Oogo S, Muniu E, Libondo J: Persistent low HIV infection in transfused sicklers as compared to high HIV infection in children presenting with other types of anaemia requiring blood transfusion. Nairobi J Med 8:26, 1992.
32. Lukin ML, Binda P, Mbensa I: Seroprevalence of HIV infected children with sickle cell anemia (abstract 0441). Int Conf AIDS 10:253, 1994.
33. Mbewe AL: HIV-1 in patients with sickle cell anemia in Zambia (abstract PC 0350). Int Conf AIDS 10(2):247, 1994.
34. Castro O, Saxinger C, Barnes S: Prevalence of antibodies to human immunodeficiency virus and to human T cell leukemia virus type 1 in transfused sickle cell disease patients. J Infect Dis 162:743, 1990.
35. Godeau B: Severe pneumococcal sepsis and meningitis in human immunodeficiency virus. Infected adults with sickle cell anemia. Clin Infect Dis 15:327, 1992.
36. McKernan, Hay CR: Early rapid decline in CD4 count released by splenectomy in HIV infection. Haemophilia 1:67, 1995.
37. Kemeny MM, Cooke V, Melester TS, Halperin IC, Burchell AR, Yee JP, Mills CB: Splenectomy in patients with AIDS and AIDS-related complex. AIDS 7:1063, 1993.
38. Zurlo JJ, Wood L, Gaglione MM, Polis MA: Effect of splenectomy on T lymphocyte subsets in patients infected with the human immunodeficiency virus. Clin Infect Dis 20:768, 1995.
39. Tunkel AR, Kelsall B, Rein MF, Innes DJ, Saulsbury FT, Vollmer K, Wispelung B: Case report: Increase in CD4 lymphocyte counts after splenectomy in HIV-infected patients. Am J Med Sci 306:105, 1993.
40. Todd J, Pachl C, White R: Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J Acquir Immune Defic Syndr Hum Retrovirol 10:S35, 1995.
41. Pachl C, Todd JA, Kern DG: Rapid and precise quantitation of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 8:446, 1995.
42. Dailey PJ, Wilber JC, Collins MC: Correlation of HIV RNA viral load in PBMCs and plasma with clinical status using branched DNA (bDNA) signal amplification (abstract). Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994.
43. Zhang H, Bagasra O, Niikura M, Poiesz BJ, Pomerantz RJ: Intravirion reverse transcripts in the peripheral blood plasma of human immunodeficiency virus type 1-infected individuals. J Virol 68:7591, 1994.
44. Bagasra O, Seshamma T, Hansen J, Pomerantz RJ: In situ polymerase chain reaction and hybridization to detect low abundance nucleic acid targets. In Ausubel FM, ed. Current Protocols in Molecular Biology, New York: John Wiley & Sons, 1995, Sec 14.8.1.
45. Todd J, Yeghiazarian T, Hoo B: Quantitation of human immunodeficiency virus plasma RNA by branched DNA and reverse transcription coupled polymerase chain reactions assay methods: A critical evaluation of accuracy and reproducibility. Serodiagn Immunother Infect Dis 6:1, 1994.
46. Cao Y, Ho DD, Todd J: Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses 11:353, 1995.
47. Dewar RL, Highbarger HC, Sarmiento MD: Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 170:1172, 1994.
48. Lackritz EM, Satten GA, Aberle-Grasse J: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 333:172, 1995.
49. Ferbas J, Kaplan AH, Hausner MA, et al.: Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocytic activity. J Infect Dis 172:329, 1995.
50. Cocchi F, DeVico AL, Garzino-Demo A: Identification of RANTES, MIP-1α and MIP-1β as the major HIV suppressive factors produced by CD8+ T cells. Science 270:1811, 1995.
51. Bagnarelli P, Menzo S, Valenza A: Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol 66:7328, 1992.
52. Cocchi F, DeVieo AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P: The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine mediated blockade of infection. Nature Med 2:1244, 1996.
53. Michael NL, Chang G, D'Arcy LA: Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivors lacking recoverable virus. J Virol 69:4228, 1995.
54. Clerici M, Stocks NI, Zajac RA: Detection of three distinct patterns of T-helper cell dysfunction in asymptomatic human immunodeficiency virus-seropositive patients. J Clin Invest 84:1892, 1989.
55. Jurriaans S, Gemen B, Weverling GJ: The natural history of HIV-1 infection: Are virus load and virus phenotype independent determinants of clinical course? Virology 204:223, 1994.
56. Henry K, Erice A, Dailey P, Posalak Z, Melroe H: Acute effect of splenectomy on the levels of HIV RNA in plasma (abstract) 3rd Conference on Retroviruses and Opportunistic Infections. Washington, DC, #245, January 28-February 1, 1996.
57. Oksenhendler E, Bierling P, Chevret S: Splenectomy is safe and effective in human immunodeficiency virus-related immune thrombocytopenia. Blood 82(1):29, 1993.
58. Gobarre J, Azar N, Othman T: Long-term effects of splenectomy for immune thrombopenic purpera related to human immunodeficiency virus: A retrospective study from two groups with and without splenectomy. Presse Med 20(44):2239, 1991.
59. Leissinger C, Haislip A, Tenenbaum S, Sander D, Garry R: Changes in HIV-1 proviral DNA levels and lymphocyte population in HIV infected patients after splenectomy. Blood 88(10):931A, 1995.
60. mac infection in Chinese and Indian rhesus macaques: Effects of splenectomy on virus burden. Virology 200:436, 1994.